About one in five people walks around with a heart attack risk baked into their DNA that a standard cholesterol panel completely misses. Your LDL can be textbook. Your diet can be spotless. And you can still be carrying a particle that, decade after decade, is grinding away at your arteries. It is called lipoprotein(a), written Lp(a) and said “L-P-little-a,” and most people have never had it measured even once.
That is the strange thing about it. We test cholesterol reflexively, sometimes yearly. Lp(a) is arguably more informative because your number barely moves over a lifetime, so you only need to check it once. Yet it almost never appears on a routine order.
What this particle actually is
Lp(a) is an LDL particle with an extra protein bolted onto it called apolipoprotein(a). Picture a normal LDL cholesterol particle, then imagine a long, tangled tail wrapped around it. That tail is the troublemaker. It makes the particle stickier inside artery walls, and its structure happens to resemble plasminogen, a protein your body uses to dissolve clots. So Lp(a) does double damage: it drives plaque like LDL, and it interferes with the machinery that breaks down clots, which is a nasty combination in the moments a plaque ruptures.
Here is what sets it apart from nearly every other cardiovascular risk factor. Your Lp(a) level is roughly 80 to 90 percent determined by the gene you inherited for apolipoprotein(a). It is set close to birth. It does not care about your saturated fat intake, your exercise, or your weight. Statins do not lower it, and in some people nudge it slightly upward. This is not a lifestyle number. It is closer to your blood type.
The genetics make the case hard to argue with
Most of what we know about ordinary cholesterol comes from observational studies, which show association and leave room for doubt about cause. Lp(a) is different, and the reason is elegant. Because the level is set by a single gene region, researchers can use a method called Mendelian randomization: since genes are shuffled essentially at random at conception, people who inherited high-Lp(a) variants are like a lifelong randomized trial nature ran for us.
When you do that, the variants that raise Lp(a) track directly with coronary disease. A large genetic analysis found that the specific gene variants controlling Lp(a) levels were strongly associated with coronary risk, which is the signature of cause rather than coincidence NEJM, 2009. Pooled data across dozens of cohorts found that higher Lp(a) concentration was continuously associated with coronary heart disease and stroke, independent of standard lipids JAMA, 2009.
It does not stop at coronary arteries. The same particle turns up in the story of calcific aortic stenosis, the slow stiffening of the heart’s main outflow valve that eventually needs surgical replacement. Genetic work again pointed to Lp(a) as a causal driver of aortic valve calcification, not just a bystander NEJM, 2013. If you have ever wondered why some people with clean arteries still develop a stiff valve in their seventies, this is often the answer.
Where you stand
Labs report Lp(a) two ways, and the units cause endless confusion. Mass (mg/dL) and particle count (nmol/L) do not convert cleanly, so make sure you know which one your report uses. Roughly:
| Lp(a) level | mg/dL | nmol/L | Population |
|---|---|---|---|
| Low risk | under 30 | under 75 | majority |
| Borderline | 30 to 50 | 75 to 125 | intermediate |
| High risk | over 50 | over 125 | about 1 in 5 |
| Very high | over 90 | over 200 | about 1 in 20 |
The higher end matters more than the table suggests. People in the top few percent can carry two to three times the lifetime risk of a heart attack compared with people who have low levels, and they get there younger.
What to do on Monday
Ask for the test. One blood draw, once in your life, ideally before age 50 but useful at any age. Many labs run it for the cost of a couponed cholesterol panel, and you never have to fast or repeat it. If you have a parent or sibling who had a heart attack or stroke before 60, or a family history of aortic valve replacement, move it to the top of your list. Lp(a) clusters in families for the obvious reason.
If your number comes back high, do not panic, and do not conclude your fate is sealed. Genetics loads the gun, but the outcome is still an arithmetic problem. Lp(a) is one input into total arterial burden, and the other inputs are yours to control. That means driving your apoB and LDL lower and keeping them there, since the plaque that forms is still built from cholesterol particles regardless of which type started it. If you have not read up on the number that actually drives that risk, start with our piece on apoB. Blood pressure control, not smoking, and cardiorespiratory fitness all matter more, not less, when you carry a fixed genetic risk on top.
There is one honest caveat. No approved drug yet lowers Lp(a) specifically and then proves that doing so prevents heart attacks. Several injectable therapies that cut Lp(a) by 80 percent or more are in large outcome trials right now, with results expected in the next few years. Until those read out, the treatment is aggressive management of everything else, which is worth doing anyway.
Knowing your Lp(a) will not change your genes. It changes the intensity with which you defend the rest of the board, and it explains the family history that a normal cholesterol panel never could.